Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2466 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3294 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3297 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-1787 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3247 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2005-3267 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-347 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3271 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-3298 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-31545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-284 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M5-2448 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-28 |
filingDate |
2011-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2013-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2013518642-A |
titleOfInvention |
Medicinal module with double needle guard |
abstract |
The medicated module (100) is attachable to the drug delivery device (102). The medicated module (100) includes a housing (104) having a proximal end and a distal end, the proximal end having a connector (110) configured for attachment to a drug delivery device (102). The distal end includes a shuttle (112). The first needle (114) is secured to the housing (104) and the second needle (116) is secured to the shuttle (112). The medicated module (100) also includes a reservoir (118) in a housing (104) that includes the drug (120). In addition, the medicated module (100) includes a guard assembly (122) located in the housing (104) and configured to move axially during application to the injection site. Preferably, the medicated module (100) is locked out after at least two injections of the medicament (105) included in the drug delivery device (102). [Selection] Figure 1 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018535039-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101548458-B1 |
priorityDate |
2010-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |